z-logo
open-access-imgOpen Access
Paving Plant‐Food‐Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder
Author(s) -
Natália Martins,
Cristina Quispe,
Celale Kırkın,
Ezgi Şenol,
Aslı Zuluğ,
Beraat Özçelik,
Adedayo O. Ademiluyi,
Olubukola H. Oyeniran,
Prabhakar Semwal,
Manoj Kumar,
Farukh Sharopov,
Víctor López,
Francisco Les,
Iulia Cristina Bagiu,
Monica Butnariu,
Javad SharifiRad,
Mohammed M. Alshehri,
William C. Cho
Publication year - 2021
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2021/1131280
Subject(s) - autism , autism spectrum disorder , neuropsychology , resveratrol , neurodevelopmental disorder , neuroprotection , medicine , psychiatry , psychology , cognition , pharmacology
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, where social and communication deficits and repetitive behaviors are present. Plant-derived bioactives have shown promising results in the treatment of autism. In this sense, this review is aimed at providing a careful view on the use of plant-derived bioactive molecules for the treatment of autism. Among the plethora of bioactives, curcumin, luteolin, and resveratrol have revealed excellent neuroprotective effects and can be effectively used in the treatment of neuropsychological disorders. However, the number of clinical trials is limited, and none of them have been approved for the treatment of autism or autism-related disorder. Further clinical studies are needed to effectively assess the real potential of such bioactive molecules.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom